This project has a Band 3 fee. Details of our different fee bands can be found on our website (View Website). For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (View Website).
As an equal opportunities institution we welcome applicants from all sections of the community regardless of gender, ethnicity, disability, sexual orientation and transgender status. All appointments are made on merit.
1. Bertuzzi M, Hayes G, Icheoku U, Osherov N, Bignell E (2018) Anti-Aspergillus activities of the respiratory epithelium in health and disease Journal of Fungi In Press
2. Loss O, Bertuzzi M, Yu Y, Fedorova N, McCann B, Armstrong-James D, Espeso E, Read N, Nierman W, Bignell E (2017) Mutual independence of alkaline- and calcium-mediated signalling in Aspergillus fumigatus refutes the existence of a conserved druggable signalling nexus Molecular Microbiology 106:861-875
3. Johns A, Scharf DH, Gsaller F, Schmidt H, Heinekamp T, Straßburger M, Oliver JD, Birch M, Beckmann N, Dobb KS, Gilsenan J, Rash B, Bignell E, Brakhage AA, Bromley MJ. 2017. A nonredundant phosphopantetheinyl transferase, PptA, is a novel antifungal target that directs secondary metabolite, siderophore, and lysine biosynthesis in Aspergillus fumigatus and is critical for pathogenicity mBio 8:e01504-16
4. Bignell, E., Cairns, T. C., Throckmorton, K., Nierman, W. C. & Keller, N. P. (2016) Secondary metabolite arsenal of an opportunistic pathogenic fungus Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 371:1709 [IF 6.9]
5. Amich Elias, J., & Bignell, E. (2016). Amino acid biosynthetic routes as drug targets for pulmonary fungal pathogens: what is known and why do we need to know more? Current Opinion in Microbiology, 32, 151-158. [IF 6.9]